Pharmacological plasticity of GABAA receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy

Journal of Physiology

Volumn 557, Issue 2, 2004, Pages 473-487

  Leroy, Claire ^a   Poisbeau, Pierrick ^b   Keller, A Florence ^b   Nehlig, Astrid ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; DIAZEPAM; FLUMAZENIL; LITHIUM; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING SITE; BRAIN SLICE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROPHYSIOLOGY; EPILEPTIC STATE; EPILEPTOGENESIS; GRANULE CELL; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE EPILEPSY; ADULT; ALLOSTERISM; ANIMAL CELL; ARTICLE; MINIATURE INHIBITORY POSTSYNAPTIC CURRENT; RAT MODEL; SPRAGUE DAWLEY RAT; SYNAPSE; UPREGULATION; WHOLE CELL PATCH CLAMP;

ANIMALS; ANTICONVULSANTS; DENTATE GYRUS; DIAZEPAM; DISEASE MODELS, ANIMAL; ELECTRIC CONDUCTIVITY; EPILEPSY, TEMPORAL LOBE; FLUMAZENIL; GABA MODULATORS; LITHIUM; MALE; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; PILOCARPINE; PREGNANOLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; STATUS EPILEPTICUS; SYNAPSES;

EID: 3042684380     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2003.059246     Document Type: Review

References (71)

1. Alho H, Bovolin P, Jenkins D, Guidotti A & Costa E (1989). Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. J Chem Neuroanat 2, 301-318.
2. André V, Marescaux C, Nehlig A & Fritschy J-M (2001). Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11, 452-468.
3. Ball JA, Ghatei MA, Sekiya K, Krausz T & Bloom SR (1989). Diazepam binding inhibitor-like immunoreactivity (51-70): distribution in human brain, spinal cord and peripheral tissues. Brain Res 479, 300-305.
4. Barbaccia ML, Serra M, Purdy RH & Biggio G (2001). Stress and neuroactive steroids. Int Rev Neurobiol 46, 243-272.
5. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup AN & Langer SZ (1998). International union of pharmacology. XV. Subtypes of γ-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50, 291-313.
6. Behr J, Lyson KJ & Mody I (1998). Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol 79, 1726-1732.
7. A receptors. Neuropharmacology 43, 651-661.
8. A receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J Neurosci 23, 10013-10020.
9. A receptor channels from low- to high-efficacy gating patterns. J Neurosci 23, 10934-10943.
10. Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY & Coulter DA (1998). Selective changes in single cell GABA (A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4, 1166-1172.
11. Buhl EH, Otis TS & Mody I (1996). Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271, 369-373.
12. Buldakova S & Weiss M (1997). Electrophysiological evidence for agonist properties of flumazenil, a benzodiazepine receptor antagonist, in rat hippocampus slices. J Neurol Sci 149, 121-126.
13. Cavalheiro EA (1995). The pilocarpine model of epilepsy. Ital J Neurol Sci 16, 33-37.
14. A receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci 17, 1607-1616.
15. Cooper EJ, Johnston GA & Edwards FA (1999). Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices. J Physiol 521, 437-449.
16. Engel J Jr (1998). Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention. Neurology 51, 1243-1244.
17. Ferrarese C, Cogliati T, Tortorella R, Zucca C, Bogliun G, Beghi E, Passoni D, Zoia C, Begni B, Airoldi L, Alho H & Fratolla L (1998). Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res 29, 129-134.
18. Fritschy JM, Kiener T, Bouilleret V & Loup F (1999). GABAergic neurons and GABA(A)-receptors in temporal lobe epilepsy. Neurochem Int 34, 435-445.
19. Frye CA & Scalise TJ (2000). Anti-seizure effects of progesterone and 3alpha,5alpha-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25, 407-420.
20. A receptor function in dentate granule and CA1 neurons. J Neurophysiol 77, 1924-1938.
21. Grosso S, Luisi S, Mostardini R, Farnetani M, Cobellis L, Morgese G, Balestri P & Petraglia F (2003). Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children. Epilepsy Res 54, 29-34.
22. Hart YM, Meinardi H, Sander JW, Nutt DJ & Shorvon SD (1991). The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study. J Neurol Neurosurg Psychiatry 54, 305-309.
23. Hauser CA, Wetzel CH, Berning B, Gerner FM & Rupprecht R (1997). Flunitrazepam has an inverse agonistic effect on recombinant alpha6beta2gamma2-GABAA receptors via a flunitrazepam-binding site. J Biol Chem 272, 11723-11727.
24. Jones DM, Esmaeil N, Maren S & Macdonald RL (2002). Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 50,301-312.
25. A receptor function and pharmacology in epilepsy and status epilepticus. Cur Opin Pharmacol 3, 12-18.
26. Jope RS, Song L & Kolasa K (1992). Inositol triphosphate, cyclic AMP, and cyclic GMP in rat brain region after lithium and seizures. Biol Psychiatry 31, 505-514.
27. A receptors. J Neurosci 17, 7532-7540.
28. King GL, Knox JJ & Dingledine R (1985). Reduction of inhibition by a benzodiazepine antagonist, Ro 15-1788, in the rat hippocampal slice. Neuroscience 15, 371-378.
29. Kittler JT & Moss SJ (2003). Modulation of GABAA receptor by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Cur Opin Pharmacol 13, 341-347.
30. Klein RL, Mascia MP, Harkness PC, Hadingham KL, Whiting PJ & Harris RA (1995). Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA) A receptors by chronic treatment with GABAA and benzodiazepine agonists. J Pharmacol Exp Ther 274, 1484-1492.
31. Kokate TG, Yamaguchi S-I, Pannell LK, Rajamani U, Carroll DM, Grossman AB & Rogawski MA (1998). Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. J Pharmacol Exp Ther 287, 553-558.
32. A receptors. Cell Mol Neurobiol 16, 155-174.
33. A receptor function. Trends Pharmacol Sci 16, 295-303.
34. A receptors. Progr Neurobiol 71, 67-80.
35. Laurie DJ, Widsen W & Seeburg PH (1992). The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12, 4151-4172.
36. A receptors containing an α 5 subunit. Eur J Pharmacol 413, 63-72.
37. Lothman EW, Stringer JL & Bertram EH (1992). The dentate gyrus as a control point for seizures in the hippocampus and beyond. Epilepsy Ressupplement 7, 301-313.
38. Loup F, Wieser HG, Yonekawa Y, Aguzzi A & Fritschy J-M (2000). Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 20, 5401-5419.
39. Lugaresi E, Montagna P, Tinuper P, Plazzi G, Gallassi R, Wang TC, Markey SP & Rothstein JD (1998). Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. Brain 121, 127-133.
40. Lyons HR, Gibbs TT & Farb DH (2000). Turnover and down-regulation of GABA (A) receptor alpha1, beta2S, and gamma 1 subunit mRNAs by neurons in culture. J Neurochem 74, 1041-1048.
41. Mathern GW, Babb TL & Armstrong DL (1997). Hippocampal sclerosis. In Epilepsy, a Comprehensive Textbook, ed.Engel, J & Pedley, TA, pp. 133-155. Lippincott-Raven Publishers, Philadelphia.
42. Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, Delorey TM, Olsen RW & Homanics GE (1999). Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A 96, 12905-12910.
43. A receptors responsible for tonic and phasic conductances. Neurochem Res 26, 907-913.
44. Mody I, De Koninck Y, Otis TS & Soltesz I (1994). Bridging the cleft at GABA synapses in the brain. Trends Neurosci 17, 517-525.
45. A receptor currents in a rat model of chronic temporal lobe epilepsy. J Physiol 537, 453-465.
46. Mtchedlishvili Z, Sun CS, Harrison MB & Kapur J (2003). Increased neurosteroid sensitivity of hippocampal GABAA receptors during postnatal development. Neuroscience 118, 655-666.
47. Nusser Z, Hajos N, Somogyi P & Mody I (1998). Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395, 172-177.
48. Otis TS, De Koninck Y & Mody I (1994). Lasting potentiation of inhibition is associated with an increased number of gamma-aminobutyric acid type A receptors activated during miniature inhibitory postsynaptic currents. Proc Natl Acad Sci USA 91, 7698-7702.
49. Patrylo PR, Spencer DD & Williamson A (2001). GABA uptake and heterotransport are impaired in the dentate gyrus of epileptic rats and humans with temporal lobe epilepsy. J Neurophysiol 85, 1533-1542.
50. Poisbeau P, Cheney MC, Browning MD & Mody I (1999). Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons. J Neurosci 19, 674-683.
51. A synapses during flurazepam withdrawal are region specific in the hippocampus formation. J Neurosci 17, 3467-3475.
52. Polc P, Jahromi SS, Facciponte G, Pelletier MR, Zhang L & Carlen PL (1995). Benzodiazepine antagonist flumazenil reduces hippocampal epileptiform activity. Neuroreport 6, 1549-1552.
53. Purdy RH, Morrow AL, Moore PH Jr & Paul Sm (1991). Stress-induced elevations of γ-aminobutyric acid type A receptor-active teroids in the rat brain. Proc Natl Acad Sci U S A 88, 4553-4557.
54. Reisner-Keller LA & Pham Z (1995). Oral flumazenil in the treatment of epilepsy. Ann Pharmacother 29, 530-531.
55. Rice A, Rafiq A, Shapiro SM, Jakoi ER, Coulter DA & Delorenzo RJ (1996). Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci U S A 93, 9665-9669.
56. Roch C, Leroy C, Nehlig A & Namer IJ (2002). Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 43, 325-335.
57. Rothstein JD, Guidotti A, Tinuper P, Cortelli P, Avoni P, Plazzi G, Lugaresi E, Schoch P & Montagna P (1992). Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor. Lancet 340, 1002-1004.
58. Sand P, Kavvadias D, Feineis D, Riederer P, Schreier P, Kleinschnitz M, Czygan FC, Abou-Mandour A, Bringmann G & Beckmann H (2000). Naturally occurring benzodiazepines: current status of research and clinical implications. Eur Arch Psychiatry Clin Neurosci 250, 194-202.
59. Schwarzer C, Tsunashima K, Wanzenbock C, Fuchs K, Sieghart W & Sperk G (1997). GABA(A) receptor subunits in the rat hippocampus II: altered distribution in kainic acid-induced temporal lobe epilepsy. Neuroscience 80, 1001-1017.
60. Sharief MK, Sander JW & Shorvon SD (1993). The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study. Epilepsy Res 15, 53-60.
61. Shumate MD, Lin DD, Gibbs JW, 3rd Holloway KL & Coulter DA (1998). GABA(A) receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat. Epilepsy Res 32, 114-128.
62. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392, 926-930.
63. A receptor α4 subunit in association with increased anxiety. J Neurosci 18, 5275-5284.
64. Spigelman I, Li Z, Banerjee PK, Mihalek RM, Homanics GE & Olsen RW (2002). Behavior and physiology of mice lacking the GABAA-receptor delta subunit. Epilepsia 43, 3-8.
65. Stell BM, Tang CY, Farrant M & Mody I (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by {delta} subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100, 14439-14444.
66. Thomson AM, Bannister AP, Hughes DI & Pawelzik H (2000). Differential sensitivity to Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus. Eur J Neurosci 12, 425-436.
67. Tietz EI, Zeng XJ, Chen S, Lilly SM, Rosenberg HC & Kometiani P (1999). Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance. J Pharmacol Exp Ther 291, 932-942.
68. Vicini S, Losi G & Homanics GE (2002). GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology 43, 646-650.
69. A receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nature Genet 28, 49-52.
70. A receptors in isolated rat hippocampal neurons. Neurochem Res 27, 1605-1612.
71. Whittemore ER, Yang W, Drewe JA & Woodward RM (1996). Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes. Mol Pharmacol 50, 1364-1375.